EPIPEN4SCHOOLS® Survey Combined Analysis: Prevalence and Triggers of Anaphylactic Events
White, M. V., Silvia, E., Hollis, K., Wooddell, M. J., Goss, D., Odom, D., ... Hogue, S. (2016). EPIPEN4SCHOOLS® Survey Combined Analysis: Prevalence and Triggers of Anaphylactic Events. Journal of Allergy and Clinical Immunology, 137(2 [Supplement]), AB52. DOI: 10.1016/j.jaci.2015.12.173
The EPIPEN4SCHOOLS® program (Mylan Specialty L.P., Canonsburg, PA) provides EpiPen® (epinephrine injection) Auto-Injectors to qualifying public and private US schools. Results of a pilot survey described characteristics of anaphylactic events occurring in an initial set of participating schools during the 2013-2014 school year. This survey was subsequently readministered to large US school districts (≥50 schools per district), which were underrepresented in initial survey findings. Here, data from schools in large districts were added to initial findings in a comprehensive combined analysis.